GINGER CONSTANTINE

MALVERN, PA

General Payments — all program years on this page

$103,085.25

  • Category: General Payments
  • Program years: PY2018–2020
  • Record count: 18
  • As of (CMS publication): 2026-01-23

Latest program year (PY2020): $11,179.41 across 3 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2020) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $11,179.413

By paying entity

Latest program year (PY2020) · sorted by reported total.

Paying entityAmountRecords
AMAG Pharmaceuticals, Inc. $11,179.413

By program year

Program yearAmountRecords
2018 $8,683.939
2019 $83,221.916
2020 $11,179.413

Records — PY2020 (3)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
753006317 AMAG Pharmaceuticals, Inc. $5,500.00 01/08/2020 Consulting Fee Undisputed 01/23/2026 View at CMS
753006319 AMAG Pharmaceuticals, Inc. $679.41 01/22/2020 Consulting Fee Undisputed 01/23/2026 View at CMS
753006321 AMAG Pharmaceuticals, Inc. $5,000.00 01/22/2020 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.